These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 21083449

  • 1. Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.
    Lehrnbecher T, Creutzig U.
    Expert Rev Hematol; 2009 Apr; 2(2):159-72. PubMed ID: 21083449
    [Abstract] [Full Text] [Related]

  • 2. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001 Apr; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

  • 3. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
    Lehrnbecher T.
    Klin Padiatr; 2001 Apr; 213(4):212-38. PubMed ID: 11528556
    [Abstract] [Full Text] [Related]

  • 4. Hematopoietic growth factors in the reduction of chemotherapeutic toxicity.
    Johnston EM, Crawford J.
    Semin Oncol; 1998 Oct; 25(5):552-61. PubMed ID: 9783594
    [Abstract] [Full Text] [Related]

  • 5. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
    Ottmann OG, Bug G, Krauter J.
    Semin Hematol; 2007 Jul; 44(3):183-92. PubMed ID: 17631182
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR.
    J Clin Oncol; 2004 Aug 15; 22(16):3350-6. PubMed ID: 15310780
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hematopoietic growth factors in the prevention of infections complications in children with hematologic-oncologic diseases].
    Lehrnbecher T.
    Klin Padiatr; 2001 Sep 15; 213 Suppl 1():A88-102. PubMed ID: 11577368
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar 15; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 11. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C, Coleman DL.
    Schweiz Med Wochenschr; 1991 Mar 23; 121(12):397-412. PubMed ID: 1709294
    [Abstract] [Full Text] [Related]

  • 12. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
    Lehrnbecher T.
    Z Geburtshilfe Neonatol; 2001 Mar 23; 205(5):167-73. PubMed ID: 11727663
    [Abstract] [Full Text] [Related]

  • 13. [The efficacy of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of solid tumors in children. Report of Polish Pediatric Leukemia/Lymphoma Treatment Group].
    Chybicka A, Bogusławska-Jaworska J, Rosińska B, Wecławek-Tompol J, Armata J, Balcerska A, Balwierz W, Bubała H, Drabko K, Eliasińska A, Kedziora M, Kołecki P, Kowalczyk J, Matysiak M, Płoszyńska A, Rokicka-Milewska R, Sońta-Jakimczyk D, Sopyło B, Stefaniak MJ, Stańczak E, Stencel D, Wysocki M.
    Wiad Lek; 1998 Mar 23; 51 Suppl 4():65-71. PubMed ID: 10731946
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic use of colony stimulating factors for established neutropenic fever.
    Walton SM.
    W V Med J; 1998 Mar 23; 94(1):26-8. PubMed ID: 9505567
    [Abstract] [Full Text] [Related]

  • 15. [The effectiveness of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of non-Hodgkin's lymphoma in children. Report of Polish Pediatric Leukemia/Lymphoma Treatment Group].
    Chybicka A, Bogusławska-Jaworska J, Rosińska B, Wecławek-Tompol J, Armata J, Balcerska A, Balwierz W, Bubała H, Drabko K, Eliasińska A, Kedziora M, Sońta-Jakimczyk D, Sopyło B, Kołecki P, Kowalczyk J, Matysiak M, Rokicka-Milewska R, Stefaniak MJ, Stańczak E, Stencel D, Wysocki M, Płoszyńska A.
    Wiad Lek; 1998 Mar 23; 51 Suppl 4():72-8. PubMed ID: 10731947
    [Abstract] [Full Text] [Related]

  • 16. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
    Duru F, Ertem U, Taçyildiz N, Kirazli S.
    J Med; 1995 Mar 23; 26(5-6):241-52. PubMed ID: 8721901
    [Abstract] [Full Text] [Related]

  • 17. Granulocytic colony-stimulating factors (G-CSF and GM-CSF) in the treatment of adult acute myeloid leukemia.
    Dombret H, Toubert ME, Schlageter MH, Chomienne C, Degos L.
    Nouv Rev Fr Hematol (1978); 1991 Mar 23; 33(6):445-8. PubMed ID: 1726333
    [Abstract] [Full Text] [Related]

  • 18. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS, Sen R, Dixit G.
    J Assoc Physicians India; 2008 Dec 23; 56():942-4. PubMed ID: 19322972
    [Abstract] [Full Text] [Related]

  • 19. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY, Xu B, Sun J, Yang Y, Niu JN.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep 23; 24(9):1051-2. PubMed ID: 15447861
    [Abstract] [Full Text] [Related]

  • 20. [The efficacy of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of acute leukemia in children].
    Rokicka-Milewska R, Pawelec K, Bogusławska-Jaworska J, Chybicka A, Rosińska B, Stańczak E, Matysiak M, Sońta-Jakimczyk D, Bubała H, Kołecki P, Boruczkowski D, Wysocki M, Kurylak A.
    Wiad Lek; 1998 Sep 23; 51 Suppl 4():59-64. PubMed ID: 10731945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.